CDKN2A and cancer: P16INK4a,as a member of the INK4a family, is known to inactivate cell cycle progression and differentiation by interfering with cyclin D–CDK4/6 assembly and thus block the G1 to S transition[37].The functional loss of INK4a family has been found in variable human cancers.